What is already known about this topic?
Risk factors for BKV are aggressive immunosuppression, high human leukocyte antigen (HLA) mismatch, ureteral stent use, rejection therapy, prolonged ischemia duration, advanced age, male recipient, diabetes mellitus (DM), lymphocyte depleting induction therapies, tacrolimus, and mycophenolate- based regimens.